Pharmacologic treatments for covid-19 patients
vs
To access all information :
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=177
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| NCT04391712 Vetrici MA, J Inflamm Res, 2021 Full text Commentary |
No specific funding |
Photobiomodulation therapy |
Standard care |
RCT | Patients with confirmed COVID-19 (moderate-severe) admitted to a single center in the USA | N=10 |
Some concerns Details |
|
| NCT04386694 De Marchi T, J Inflamm Res, 2021 Full text Full text Commentary Commentary |
Mixed |
Photobiomodulation therapy |
Placebo |
RCT | Patients with confirmed COVID-19 (critical) admitted to a single center in Brazil. | N=30 |
Some concerns Details |
|